TMO · Thermo Fisher Scientific, Inc.
AI read · Good for TMO
The AI's read
The company’s core business showed growth, with sales and adjusted profit both beating estimates. It also raised its 2026 ranges, though the new figures sit close to what analysts had expected. The new authorization gives the board room to return cash, but it does not promise that all the money will be spent.